REQUEST A DEMO
Total
USD $0.00
Search more companies

Ump Tomskfarmaciya (Умп Томскфармация) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Ump Tomskfarmaciya Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Ump Tomskfarmaciya (Умп Томскфармация) is based in Russia, with the head office in Tomsk. It operates in the Pharmacies and Drug Stores industry. It was established on November 23, 2020. It currently has a total number of 158 (2009) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 99.83% in 2024. Its total assets decreased by 99.74% over the same period. The net profit margin of Ump Tomskfarmaciya (Умп Томскфармация) increased by 0.17% in 2024.

Headquarters
Rozy Lyuksemburg, 4
Tomsk; Tomsk Oblast; Postal Code: 634009

Contact Details: Purchase the Ump Tomskfarmaciya (Умп Томскфармация) report to view the information.

Basic Information
Total Employees:
Purchase the Ump Tomskfarmaciya (Умп Томскфармация) report to view the information.
Registered Capital:
Purchase the Ump Tomskfarmaciya (Умп Томскфармация) report to view the information.
Financial Auditors:
Purchase the Ump Tomskfarmaciya (Умп Томскфармация) report to view the information.
Incorporation Date:
November 23, 2020
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Argt OAO
100%
Company Performance
Financial values in the chart are available after Ump Tomskfarmaciya (Умп Томскфармация) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-99.83%
Total operating revenue
-99.83%
Operating profit (EBIT)
-99.7%
Net Profit (Loss) for the Period
-99.8%
Total assets
-99.74%
Total equity
-99.99%
Operating Profit Margin (ROS)
2%
Net Profit Margin
0.17%
Return on Equity (ROE)
149.42%
Quick Ratio
0.49%
Cash Ratio
0.87%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?